Given the above, recognizing the expression levels of COX-2 in ovarian tissue could be a valuable practice in the development of personalized therapeutic approaches, complementing the current biological diagnostic methods that rely on analyzing tumor expression of cancer antigen 125 (CA 125) and Human Epididymis Protein 4 (HE4) [55]. The gene discussed is PTGS2; the disease is neoplasm.